CClinicalTrials.gg
Not yet recruitingNCT07719400Updated Jul 22, 2026

Effects of Pelvic Floor Muscle Training Combined With Bladder Training on Some Parametrs of Men With Urinary Frequency

An interventional study of Bladder training plus pelvic floor muscle training and Bladder Training in Urinary Dysfunction, sponsored by Bingol University. Not yet recruiting. Open to male participants aged 18 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-07-22.

Sponsored by Bingol University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
Male
01

Study summary

This prospective, single-center, parallel-group, assessor-blinded randomized controlled trial will include 120 voluntary male participants who have had complaints of urinary frequency for at least 3 months and meet the inclusion criteria. Participants will be randomly allocated into two groups (Group 1: Bladder Training + Pelvic Floor Muscle Training; Group 2: Bladder Training Alone). Assessments will be repeated at baseline, at week 4, and at week 8. The primary outcome measure will be 3-day bladder diary data (24-hour voiding frequency); secondary outcomes will include the OAB-V8, ICIQ-OAB, and PGI-I scales, as well as transabdominal ultrasonographic measurements of bladder neck elevation (strength and endurance) and PVR.

Read the detailed description

Study Design:

Prospective Single-center Parallel-group 1:1 randomized Assessor-blinded RCT CONSORT-compliant

Inclusion Criteria:

Male Age 18-65 years Complaint of urinary frequency persisting for at least 3 months

On a 3-day bladder diary:

≥8 voids/24 hours Provision of written informed consent Sufficient cognitive capacity to learn pelvic floor muscle contraction

Exclusion Criteria:

Active urinary tract infection Prostate cancer Prostate surgery within the last 12 months

Neurological diseases:

Parkinson's disease Multiple sclerosis (MS) Stroke Spinal cord injury Neurogenic bladder due to diabetes mellitus Bladder stones Bladder tumor Urethral stricture

Within the last 3 months:

PFMT (pelvic floor muscle training) Biofeedback PTNS (percutaneous tibial nerve stimulation) Tibial nerve stimulation Recent dose change in antimuscarinic or β3-agonist therapy Randomization Computer-generated block randomization Block size of 4 or 6 Allocation concealment Sealed opaque envelopes

Assessment Time Points T0 = Baseline T1 = Week 6 T2 = Week 12 T3 = 6-month follow-up Primary Outcome 3-day bladder diary 24-hour voiding frequency

Secondary Outcomes OAB-V8 Symptom severity ICIQ-OAB Quality of life and symptom impact PGI-I Patient global impression of improvement

Ultrasound Measurements A) Pelvic Floor Muscle Strength Transabdominal ultrasound

During maximum voluntary contraction:

Bladder neck elevation (mm) 3 repetitions Average will be calculated

B) Pelvic Floor Muscle Endurance Following maximum contraction 10-second hold Duration of bladder neck elevation maintenance or Percentage of elevation maintained over 10 seconds

C) Post-Void Residual Volume (PVR) Via ultrasound Within the first 5 minutes after voiding Recorded in mL

Interventions Group 1 Bladder Training Urge suppression strategies Extending voiding intervals Fluid management Caffeine education ● (placeholder/bullet) Pelvic Floor Muscle Training 8 weeks

1 face-to-face session per week Home exercise program Fast contractions: 10 reps × 3 sets Maximal (sustained) contractions: 10 reps × 10 seconds each Functional contractions: To be performed when urgency is felt

Group 2 Bladder training only Same follow-up frequency Same training duration

02

Conditions studied

  • Urinary Dysfunction

Keywords

  • Pelvic Floor Muscle Training
  • Urinary Frequency
  • Pelvic Floor Function
  • Bladder Training
03

In context

Lead sponsor

Bingol University is the lead sponsor of 8 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
Male
Accepts healthy volunteers
Yes

Inclusion criteria

  • Male sex
  • Age 18-65 years
  • Complaint of urinary frequency persisting for at least 3 months
  • On a 3-day bladder diary: ≥8 voids per 24 hours
  • Provision of written informed consent Sufficient cognitive capacity to learn pelvic floor muscle contraction (assessed by clinical judgment)

Exclusion criteria

Exclusion Criteria:

  • Active urinary tract infection
  • Prostate cancer
  • Prostate surgery within the last 12 months
  • Parkinson's disease, Multiple sclerosis (MS), Stroke, Spinal cord injury
  • Neurogenic bladder due to diabetes mellitus
  • Bladder stones, Bladder tumor, Urethral stricture
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
120 participants (estimated)

Study arms

  • Active comparator
    Group 1: Intervention group

    Bladder Training + Pelvic Floor Muscle Training

    Other: Bladder training plus pelvic floor muscle training

  • Active comparator
    Group 2: Control group

    Group 2: Bladder Training Alone

    Other: Bladder Training

Interventions

  • OtherBladder training plus pelvic floor muscle training

    Bladder training includes strategies for suppressing urgency, gradually extending the intervals between voiding, managing fluid intake, and reducing caffeine consumption. The pelvic floor muscle training component involves three types of contractions: fast contractions (10 repetitions, 3 sets), maximal sustained contractions (10 repetitions, held for 10 seconds each), and functional contractions integrated into daily activities to improve real-life muscle control.

  • OtherBladder Training

    Bladder training includes strategies for suppressing urgency, gradually extending the intervals between voiding, managing fluid intake, and reducing caffeine consumption

06

What researchers measure

Primary outcomes

  1. Pelvic floor muscle strength as assessed by ultrasound

    Time frame: From enrollment to the end of treatment at 12 weeks

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Carralero-Martinez A, Munoz Perez MA, Kauffmann S, Blanco-Ratto L, Ramirez-Garcia I. Efficacy of capacitive resistive monopolar radiofrequency in the physiotherapeutic treatment of chronic pelvic pain syndrome: A randomized controlled trial. Neurourol Urodyn. 2022 Apr;41(4):962-972. doi: 10.1002/nau.24903. Epub 2022 Mar 9. PubMed 35266184 ↗
  • Siegel AL. Pelvic floor muscle training in males: practical applications. Urology. 2014 Jul;84(1):1-7. doi: 10.1016/j.urology.2014.03.016. Epub 2014 May 10. PubMed 24821468 ↗
  • Clemens JQ, Nadler RB, Schaeffer AJ, Belani J, Albaugh J, Bushman W. Biofeedback, pelvic floor re-education, and bladder training for male chronic pelvic pain syndrome. Urology. 2000 Dec 20;56(6):951-5. doi: 10.1016/s0090-4295(00)00796-2. PubMed 11113739 ↗

Individual participant data

Plan to share: Undecided

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 22, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07719400
Lead sponsor
Bingol University
Collaborators
Istanbul Rumeli University
Responsible party
Hasan Bingöl (Assoc. Prof., Bingol University) — Principal investigator
First posted
Jul 22, 2026
Start date
Sep 1, 2026 (estimated)
Primary completion
Sep 1, 2027 (estimated)
Completion
Dec 1, 2027 (estimated)
Last update
Jul 22, 2026

Study contacts

Hasan Bingöl, Assoc. Prof, PhD
Contact
hesenbingol@gmail.com
+90 0(426) 216 0012 ext. 5595

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion